A phase II study of radiosurgery and temozolomide for patients with one to four brain metastases

被引:0
|
作者
Fiveash, J. B.
Sawrie, S. M.
Guthrie, B. L.
Spencer, S. A.
Meredith, R. F.
Markert, J. M.
Nordal, R. A.
Conry, R. M.
Nabors, L. B.
机构
[1] UAB, Wallace Tumor Inst, Birmingham, AL USA
[2] UAB, Birmingham, AL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2048
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors
    Pedro Pérez Segura
    Miguel Gil
    Carmen Balañá
    Ignacio Chacón
    José Muñoz Langa
    María Martín
    Jordi Bruna
    Journal of Neuro-Oncology, 2012, 109 : 137 - 142
  • [32] Stereotactic radiosurgery for more than four brain metastases
    Lo, Simon S.
    Sloan, Andrew E.
    Machtay, Mitchell
    LANCET ONCOLOGY, 2014, 15 (04): : 362 - 363
  • [33] A Phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma
    Larkin, J. M. G.
    Hughes, S. A.
    Beirne, D. A.
    Patel, P. M.
    Gibbens, I. M.
    Bate, S. C.
    Thomas, K.
    Eisen, T. G.
    Gore, M. E.
    BRITISH JOURNAL OF CANCER, 2007, 96 (01) : 44 - 48
  • [34] Phase II study of combined radiotherapy and temozolomide in patients with cerebral metastases from lung cancer
    Hoffmann, W.
    Becker-Schiebe, M.
    Wagner, W.
    Kaiser, U.
    Dornoff, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S460 - S461
  • [35] A Phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma
    J M G Larkin
    S A Hughes
    D A Beirne
    P M Patel
    I M Gibbens
    S C Bate
    K Thomas
    T G Eisen
    M E Gore
    British Journal of Cancer, 2007, 96 : 44 - 48
  • [36] SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases
    Crouzen, J. A.
    Petoukhova, A. L.
    Broekman, M. L. D.
    Fiocco, M.
    Fisscher, U. J.
    Franssen, J. H.
    Gadellaa-van Hooijdonk, C. G. M.
    Kerkhof, M.
    Kiderlen, M.
    Mast, M. E.
    van Rij, C. M.
    Nandoe Tewarie, R.
    van de Sande, M. A. E.
    van der Toorn, P. P. G.
    Vlasman, R.
    Vos, M. J.
    van Zyp, N. C. M. G. van der Voort
    Wiggenraad, R. G. J.
    Wiltink, L. M.
    Zindler, J. D.
    BMC CANCER, 2023, 23 (01)
  • [37] SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases
    J. A. Crouzen
    A. L. Petoukhova
    M. L. D. Broekman
    M. Fiocco
    U. J. Fisscher
    J. H. Franssen
    C. G. M. Gadellaa-van Hooijdonk
    M. Kerkhof
    M. Kiderlen
    M. E. Mast
    C. M. van Rij
    R. Nandoe Tewarie
    M. A. E. van de Sande
    P. P. G. van der Toorn
    R. Vlasman
    M. J. Vos
    N. C. M. G. van der Voort van Zyp
    R. G. J. Wiggenraad
    L. M. Wiltink
    J. D. Zindler
    BMC Cancer, 23
  • [38] Stereotactic radiosurgery for patients with brain metastases
    Takiguchi, Yuichi
    Sekine, Ikuo
    Iwasawa, Shunichiro
    Kurimoto, Ryota
    Uehara, Takashi
    LANCET ONCOLOGY, 2014, 15 (07): : E247 - E248
  • [39] Early Results from a Prospective Phase II Dose Escalation Study for Neoadjuvant Radiosurgery for Brain Metastases
    Murphy, Erin S.
    Yang, Kailin
    Suh, John
    Yu, Jennifer
    Schilero, Cathy
    Mohammadi, Alireza
    Stevens, Glen
    Angelov, Lilyana
    Barnett, Gene
    Vogelbaum, Michael
    Neyman, Gennady
    Chao, Samuel
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (05): : E5 - E5
  • [40] Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study
    Siena, S.
    Crino, L.
    Danova, M.
    Del Prete, S.
    Cascinu, S.
    Salvagni, S.
    Schiavetto, I.
    Vitali, M.
    Bajetta, E.
    ANNALS OF ONCOLOGY, 2010, 21 (03) : 655 - 661